Exelixis (EXEL) Net Margin Growth (3y) (2013 - 2026)
Exelixis (EXEL) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
49,253.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
506.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Exelixis |
13.37 Bn |
12.59 Bn |
590.86 Mn |
2,467.00 |
| Date | Value |
|---|
| Apr 3, 2026 |
2,467.00 |
| Jan 2, 2026 |
4,796.00 |
| Oct 3, 2025 |
1,460.00 |
| Jul 4, 2025 |
1,568.00 |
| Apr 4, 2025 |
947.00 |
| Sep 27, 2024 |
1,023.00 |
| Jun 28, 2024 |
1,054.00 |
| Mar 29, 2024 |
818.00 |
| Dec 29, 2023 |
6,985.00 |
| Sep 29, 2023 |
1,409.00 |
| Jun 30, 2023 |
-847.00 |
| Mar 31, 2023 |
-1,163.00 |
| Dec 30, 2022 |
-3,929.00 |
| Sep 30, 2022 |
-1,809.00 |
| Jul 1, 2022 |
-37,836.00 |
| Apr 1, 2022 |
-1,590.00 |
| Oct 1, 2021 |
-4,455.00 |
| Jul 2, 2021 |
-2,206.00 |
| Apr 2, 2021 |
-5,362.00 |
| Jan 1, 2021 |
-8,408.00 |
